MEG Applied Intelligence Consulting

The Reality of AI
in Life Sciences

Your team is not the problem. The approach is. Across the industry, the numbers tell the same story. These are not technology failures. They are entirely preventable. And the cost of ignoring them is measured in time, trust, and competitive ground.

Mary Gress has spent 15 years inside the industry these numbers describe. She launched five commercial products in life sciences, winning every launch contest and earning President's Club recognition. She served as a district sales trainer and national training mentor. She designed a reimbursement algorithm later adopted by marketing.

She has not studied this from the outside. She built a career proving that new tools and new ways of working stick when the people using them are brought along from the start. That is the foundation she now brings to AI.

95%

AI pilots failWasted investment and stalled momentum across the industry.

11%

AI-ready dataOnly 11% of life sciences orgs have comprehensively organized data.

94%

Ready to learnMost employees willing — organizations not giving them training to succeed.

This Is What AI Chaos
Actually Looks Like

It looks different in every organization. But the patterns are always the same.

Pattern 01

Your AI initiative started with enthusiasm and ended as an expensive science experiment. No clear business goal, no measurable outcome, and now no one can justify the spend to the board.

Pattern 02

Your cash runway is too limited to absorb another failed pilot. Every dollar spent on ungoverned AI is a dollar not available for the commercial investments that actually move the needle.

Pattern 03

Your commercial data lives in fragmented CRMs, personal spreadsheets, and disconnected systems. AI outputs are unreliable, your team does not trust them, and decisions are still made on gut instinct.

Pattern 04

Your compliance and legal teams are not against AI. But the absence of clear guardrails has turned every pilot into a nine-month validation exercise that kills momentum before it builds.

Pattern 05

You invested in powerful tools. Your team tried them once, found them harder to use than what they knew, and quietly went back to their old workflow.

Pattern 06

Your team wants to use AI. But without role-specific training, the tools sit unused and shadow AI fills the gap in ways no one can govern or trust.

None of this is a technology failure. It is an adoption failure. And every one of these breakdowns has a structured, people-first solution.

AI Adoption Is a Translation Problem,
Not a Technology Problem

On one side

Fast-Moving AI

Algorithms, automation, and an overwhelming volume of tools competing for attention.

On the other side

Commercial Life Sciences

The highly regulated, quota-driven reality. GxP compliance, lean budgets, and sales reps who need solutions that fit their workflow. Not around it.

There are two worlds in life sciences right now.

Most organizations are stuck in the gap. No clear path. No shared language. No trusted guide.

MEG Applied Intelligence Consulting exists to bridge that gap.

The mission is straightforward: to offer practical, trusted guidance that helps commercial teams use AI safely and effectively. Without the drama, the wasted investment, or the failed pilots.

Not just implemented. Adopted. Used. Trusted. Scaled.

Why Generic Tech Vendors
Keep Getting It Wrong

A vendor can hand you a tool. What they cannot give you is 15 years of carrying the bag in life sciences sales. Mary Gress brings something no technology platform can replicate: the perspective of someone who has lived inside the commercial reality her clients are navigating.

A Native Speaker of Commercial Life Sciences

She has carried the bag across capital equipment, diagnostics, biologics, and pharmaceuticals. She understands quota pressure. She knows the skepticism of a sales rep handed yet another new tool. She does not observe this world. She comes from it.

"The resistance to AI looks exactly like the resistance to every new therapy I ever launched."

— Mary Gress

A Strategic Translator

An Executive Pharmaceutical Marketing MBA provides the strategic fluency to connect AI capabilities directly to go-to-market outcomes. Not algorithms — market share. Not data points — pathways to brand differentiation and commercial performance. Every recommendation ties back to a measurable business result.

A Certified Decoder

As a Certified AI Consultant, Mary cuts through the jargon and demystifies the black box. Every recommendation is grounded in what is safe, compliant, and built to scale. No one left behind.

The A.R.T. Framework

From tech complexity to business clarity, built on a foundation of trust. A three-phase methodology designed specifically for lean life sciences commercial teams.

Align

For teams who need a foundation before they build anything else.

⌄

When there is no shared understanding of what AI is for, every department moves in a different direction. ALIGN establishes guardrails, aligns leadership on boundaries and expectations, and translates AI into business language so your entire organization starts from the same foundation.

Roadmap

For teams whose data and compliance environment is blocking progress.

⌄

Siloed data and compliance paralysis do not disappear on their own. ROADMAP prioritizes high-impact, low-risk use cases, addresses data trust issues before they become AI outputs no one believes, and navigates your compliance environment so pilots scale in weeks, not months.

Train

For teams whose tools are ready but whose people are not.

⌄

Every person on your team needs to understand how AI serves their specific role. TRAIN embeds AI into your culture through hands-on enablement, shared playbooks, and ongoing support so no one is left behind and shadow AI never fills the gap.

The Foundation: Trust

In a regulated industry, everything rests on trust. Every phase of the A.R.T. Framework is built to earn it: with your team, your compliance function, and your leadership.

Mary handles strategy, readiness, and adoption. Technical implementation is coordinated through a trusted partner. You get one point of contact managing the entire journey from foundation to scale.

"Compliance is not the enemy of innovation. Ungoverned AI is. Build the guardrails first and you can move faster, not slower."

— Mary Gress

Where Are You Right Now?

Most commercial teams arrive at AI adoption at one of three moments. Each one has a clear next step.

The ALIGN Workshop

"We know AI matters. We are not sure where to safely start."

→ Your leadership is under pressure to move on AI. But the compliance risks are real, the data is siloed, and no one can agree on where to begin. Moving forward without a foundation is how organizations end up in Pilot Purgatory.

※ The ALIGN Workshop is your starting point.

In 1 to 2 focused days, we assess your team's readiness across people, process, and risk. We align your leadership on boundaries and expectations. We establish practical guardrails for safe, compliant commercial AI use and bring your Legal and Compliance functions in early. Not as an afterthought.

You leave with

A unified team, a shared understanding, and a clear, prioritized business case for AI. No more guessing. No compliance exposure. A foundation built for adoption.

Delivered virtually or in person

The Strategic ROADMAP

"We have alignment. We need a plan we can actually execute."

→ Your leadership is on board. But without a clear roadmap, every department is moving in a different direction, chasing the wrong priorities and burning through budget on use cases that will not move the needle.

※ The Strategic ROADMAP gives you the clarity to move with precision.

We prioritize high-impact, low-risk use cases specific to your commercial team. We build an adoption roadmap with clear sequencing, ownership, and success metrics. We define implementation-ready requirements and coordinate a trusted partner handoff so execution does not stall when strategy ends.

You leave with

A board-ready, execution-ready plan that eliminates wasted investment and gives your team a predictable path to measurable return on investment.

Delivered virtually or in person

The TRAIN Program

"We have the tools. Our team is not using them."

→ You invested in AI. The pilot ran. And now the tools are sitting unused because the team was never truly brought along. Adoption did not fail because the technology was wrong. It failed because the human work was skipped.

※ The TRAIN Program is where adoption actually happens.

We run hands-on enablement workshops alongside your implementation and provide change support to drive consistent use across every function. We build shared playbooks that prevent siloed knowledge and stay engaged as adoption matures.

You leave with

A team that uses AI consistently, confidently, and compliantly. Every person is enabled. Every function aligned. 100% adoption, sustained.

Delivered virtually or in person

Not sure which moment you are in? That is exactly what the AI Adoption Clarity Call is for.

Book Your Clarity Call

"The goal is never implementation. The goal is adoption. A tool nobody uses delivers exactly zero return."

— Mary Gress

From Wasted Investment to
Measurable Return

Adopted AI delivers in two directions.

Defense

Eliminate manual data cleanup. Navigate GxP compliance with confidence. Compress pilot-to-scale timelines from nine months to weeks. Protect your organization from regulatory and reputational exposure.

Offense

Deliver actionable insights that maximize ROI of your sales and marketing engine. Capture market share from competitors still operating manually. Drive 100% user adoption so your team hits targets.

AI moves from a high-risk cost center to a reliable engine for commercial excellence.

Why This Work
Is Credible

"We had the tools but no clear path forward. Mary aligned our leadership, navigated our compliance environment, and gave us a roadmap we could actually execute. For the first time, we knew exactly where we were going."

—

Sarah K., VP Commercial Operations

PrecisionDx Diagnostics | Diagnostics

"Our team went from skeptical to confident faster than I expected. Mary stayed with us through the entire process, made sure everyone understood their role, and built the trust that made adoption actually stick."

—

James R., Director of Sales Enablement

NovaBio Therapeutics | Biotech

📰

Industry Recognition: Mary Gress was featured in Pharmaceutical Representative Magazine, March 2010 with a byline article titled "10 Things You Can Do to Ensure You Add Value for Your Clients." A peer-published byline at the height of a front-line sales career speaks for itself.

The Happy Collision
of Two Worlds

Mary Gress

Founder, MEG Applied Intelligence Consulting

Mary Gress has spent her entire career living inside the problem she now solves. Carrying the bag in life sciences sales taught her exactly what it costs an organization when the right technology arrives before the right foundation does.

She launched biologics, trained sales teams, and earned her MBA in Pharmaceutical Marketing at Saint Joseph's University. She understood the quota pressure, the compliance complexity, and the skepticism of a team handed yet another new tool.

Then AI started making headlines. She dove in, got certified, and started creating content at the intersection of both worlds. The AI world and the life sciences commercial world were not speaking the same language — and lean commercial teams at small Biotech, MedTech, and Diagnostics companies were being left to figure it out alone.

She was fluent in both languages. She had been for years.

MEG Applied Intelligence Consulting was the natural next step: not a construct, but the authentic convergence of everything she had built and learned. A consultancy built to serve the community she came from.

Credentials

Executive Pharmaceutical Marketing MBA, Saint Joseph's University

AI Assisted Consultant Certification | Credential ID: 9621-859B-50CE-C942

Featured: Pharmaceutical Representative Magazine, March 2010

5 successful commercial product launches — President's Club recognition

Mastering the A.R.T. of AI Adoption

The Reality of AI
in Life Sciences

This Is What AI Chaos
Actually Looks Like

AI Adoption Is a Translation Problem,
Not a Technology Problem

Why Generic Tech Vendors
Keep Getting It Wrong